- Home
- OLMA vs NCA Comparison
OLMA vs NCA Comparison
Compare OLMA & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- NCA
- Stock Information
- Founded
- OLMA 2006
- NCA 1987
- Country
- OLMA United States
- NCA United States
- Employees
- OLMA N/A
- NCA N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- NCA Investment Managers
- Sector
- OLMA Health Care
- NCA Finance
- Exchange
- OLMA Nasdaq
- NCA Nasdaq
- Market Cap
- OLMA 289.0M
- NCA 280.8M
- IPO Year
- OLMA 2020
- NCA N/A
- Fundamental
- Price
- OLMA $5.18
- NCA $8.47
- Analyst Decision
- OLMA Strong Buy
- NCA
- Analyst Count
- OLMA 4
- NCA 0
- Target Price
- OLMA $24.50
- NCA N/A
- AVG Volume (30 Days)
- OLMA 688.0K
- NCA 59.6K
- Earning Date
- OLMA 05-13-2025
- NCA 01-01-0001
- Dividend Yield
- OLMA N/A
- NCA 3.92%
- EPS Growth
- OLMA N/A
- NCA N/A
- EPS
- OLMA N/A
- NCA N/A
- Revenue
- OLMA N/A
- NCA N/A
- Revenue This Year
- OLMA N/A
- NCA N/A
- Revenue Next Year
- OLMA N/A
- NCA N/A
- P/E Ratio
- OLMA N/A
- NCA N/A
- Revenue Growth
- OLMA N/A
- NCA N/A
- 52 Week Low
- OLMA $2.86
- NCA $7.77
- 52 Week High
- OLMA $16.62
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- OLMA 60.00
- NCA 46.99
- Support Level
- OLMA $4.80
- NCA $8.35
- Resistance Level
- OLMA $5.61
- NCA $8.44
- Average True Range (ATR)
- OLMA 0.38
- NCA 0.11
- MACD
- OLMA 0.02
- NCA -0.01
- Stochastic Oscillator
- OLMA 78.71
- NCA 26.32
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.